Mackenzie Financial »

Tarsus Pharmaceuticals shares owned by Mackenzie Financial

Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by Mackenzie Financial from 13F filings

Historical chart of Mackenzie Financial investment in Tarsus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tarsus Pharmaceuticals held by Mackenzie Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tarsus Pharmaceuticals by Mackenzie Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $12M 191k 62.94
2025-12-31 $202k 2.5k 82.17

More positions owned by Mackenzie Financial

Royal Bank of Canada Common Stock (RY)
Toronto-Dominion Bank/The Common Stock (TD)
State Street Corp Etp (SPY)
NVIDIA Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Bank of Montreal Common Stock (BMO)
Alphabet Common Stock (GOOGL)
Canadian Pacific Kansas City L Common Stock (CP)
Microsoft Corp Common Stock (MSFT)
Agnico Eagle Mines Common Stock (AEM)
Canadian Imperial Bank of Comm Common Stock (CM)
Manulife Financial Corp Common Stock (MFC)
Enbridge Common Stock (ENB)
Canadian Natural Resources Common Stock (CNQ)
Amazon.com Common Stock (AMZN)

View all positions for Mackenzie Financial

Top funds holding Tarsus Pharmaceuticals

BlackRock
Deep Track Capital
Rtw Investments
Jupiter Topco
Paradigm Biocapital Advisors
Henderson Group
Morgan Stanley
Vanguard Capital Management
Jennison Associates
Tang Capital Management
Millennium Management
Bank of America Corporation
Geode Capital Management
Vestal Point Capital
State Street Corporation

View all funds holding Tarsus Pharmaceuticals